Colony Capital Stock Price, News & Analysis (NYSE:CLNY)

Colony Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLNY."

Colony Capital declared a quarterly dividend on Tuesday, August 6th. Shareholders of record on Monday, September 30th will be paid a dividend of $0.11 per share on Tuesday, October 15th. This represents a $0.44 annualized dividend and a yield of 7.72%. The ex-dividend date of this dividend is Friday, September 27th. View Colony Capital's Dividend History.

Colony Capital Inc (NYSE:CLNY) posted its quarterly earnings results on Friday, August, 9th. The real estate investment trust reported $0.11 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.14 by $0.03. The real estate investment trust had revenue of $573.40 million for the quarter, compared to analysts' expectations of $669.45 million. Colony Capital had a negative net margin of 36.96% and a negative return on equity of 9.60%. The firm's revenue was down 16.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.18 earnings per share. View Colony Capital's Earnings History.

Colony Capital is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Colony Capital.

2 brokers have issued 1 year target prices for Colony Capital's stock. Their forecasts range from $8.00 to $9.00. On average, they expect Colony Capital's share price to reach $8.50 in the next twelve months. This suggests a possible upside of 49.1% from the stock's current price. View Analyst Price Targets for Colony Capital.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colony Capital in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Colony Capital.

News articles about CLNY stock have been trending somewhat negative this week, according to InfoTrie. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Colony Capital earned a daily sentiment score of -1.3 on InfoTrie's scale. They also gave press coverage about the real estate investment trust a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Colony Capital.

Colony Capital saw a decrease in short interest during the month of August. As of August 31st, there was short interest totalling 9,058,900 shares, a decrease of 8.7% from the July 31st total of 9,927,500 shares. Based on an average daily volume of 2,640,000 shares, the days-to-cover ratio is presently 3.4 days. Approximately 1.9% of the shares of the stock are sold short. View Colony Capital's Current Options Chain.

Some companies that are related to Colony Capital include Camden Property Trust (CPT), VICI Properties (VICI), Federal Realty Investment Trust (FRT), SINO LD LTD/S (SNLAY), Klepierre (KLPEF), Vereit (VER), Iron Mountain (IRM), National Retail Properties (NNN), Omega Healthcare Investors (OHI), AGNC Investment (AGNC), CyrusOne (CONE), Kimco Realty (KIM), Store Capital (STOR), Medical Properties Trust (MPW) and Gaming and Leisure Properties (GLPI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Colony Capital investors own include Energy Transfer LP Unit (ET), Portola Pharmaceuticals (PTLA), AT&T (T), New Residential Investment (NRZ), ANNALY CAP MGMT/SH (NLY), General Electric (GE), Prospect Capital (PSEC), Centurylink (CTL), Two Harbors Investment (TWO) and Blackstone Group (BX).

Colony Capital's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (14.04%), BlackRock Inc. (6.71%), Caisse DE Depot ET Placement DU Quebec (6.52%), Fosun International Ltd (1.39%), Charles Schwab Investment Management Inc. (0.95%) and Nuveen Asset Management LLC (0.93%). Company insiders that own Colony Capital stock include Craig M Hatkoff, Neale Redington and Raymond C Mikulich. View Institutional Ownership Trends for Colony Capital.

CLNY stock was sold by a variety of institutional investors in the last quarter, including Fosun International Ltd, BlackRock Inc., Tensile Capital Management LLC, Bank of America Corp DE, Asset Management One Co. Ltd., Jennison Associates LLC, Jennison Associates LLC and Wells Fargo & Company MN. View Insider Buying and Selling for Colony Capital.

CLNY stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, Charles Schwab Investment Management Inc., Renaissance Technologies LLC, Boston Partners, Prudential Financial Inc., Parametric Portfolio Associates LLC and First Trust Advisors LP. Company insiders that have bought Colony Capital stock in the last two years include Craig M Hatkoff and Raymond C Mikulich. View Insider Buying and Selling for Colony Capital.

Shares of CLNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CLNY stock can currently be purchased for approximately $5.70.

Colony Capital has a market capitalization of $2.78 billion and generates $2.67 billion in revenue each year. The real estate investment trust earns $-519,610,000.00 in net income (profit) each year or $0.62 on an earnings per share basis. Colony Capital employs 400 workers across the globe.View Additional Information About Colony Capital.

The official website for Colony Capital is http://www.clny.com/.

Colony Capital's mailing address is 515 SOUTH FLOWER STREET 44TH FLOOR, LOS ANGELES CA, 90071. The real estate investment trust can be reached via phone at 310-282-8820 or via email at [email protected]